Patent details

EP2640854 Title: PCAT1 ncRNA AND USES THEREOF

Basic Information

Publication number:
EP2640854
PCT Application Number:
US2011061204
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP118408400
PCT Publication Number:
WO2012068383
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PCAT1 ncRNA AND USES THEREOF
French Title of Invention:
ARNnc PCAT1 ET UTILISATIONS DE CELUI-CI
German Title of Invention:
PCAT1 NC-RNA UND VERWENDUNG DAVON
SPC Number:

Dates

Filing date:
17/11/2011
Grant date:
21/02/2018
EP Publication Date:
25/09/2013
PCT Publication Date:
24/05/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/02/2018
EP B1 Publication Date:
21/02/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/11/2018
Expiration date:
17/11/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/02/2018
 
 

Name:
The Regents of The University of Michigan
Address:
1600 Huron Parkway 2nd Floor, Ann Arbor, Michigan 48109, United States (US)

Inventor

1

Name:
CHINNAIYAN, Arul
Address:
United States (US)

2

Name:
PRENSNER, John
Address:
United States (US)

3

Name:
IYER, Matthew
Address:
United States (US)

Priority

Priority Number:
415490 P
Priority Date:
19/11/2010
Priority Country:
United States (US)

Classification

IPC classification:
G01N 33/574; C12N 15/113; C12Q 1/68;

Publication

European Patent Bulletin

1

Issue number:
201808
Publication date:
21/02/2018
Description:
Grant (B1)

2

Issue number:
201811
Publication date:
14/03/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2019 Outgoing Correspondence 1